Objective This study aimed to determine the safety and effectiveness of DTI-assisted neuroendoscopy for treating intracranial hemorrhage (ICH). Methods This retrospective study included clinical data from 260 patients with spontaneous supratentorial ICH who received neuroendoscopic hematoma removal. Patients were separated into groups based on the surgery method they received: DTI-assisted neuroendoscopy (69 cases) and standard neuroendoscopy (191 cases). All patients were followed up for 6 months. Multivariate logistic regression analyzed the risk factors affecting the prognosis of patients. The outcomes of the two groups were compared using Kaplan–Meier survival curves. Results The prognostic modified Rankin Scale (mRS) score was significantly better ( P = 0.027) in the DTI-assisted neuroendoscopy group than in the standard neuroendoscopy group. Logistic regression analysis showed that DTI-assisted neuroendoscopy is an independent protective factor for a favorable outcome (model 1: odds ratio [OR] = 0.42, P = 0.015; model 2: OR = 0.40, P = 0.013). Kaplan–Meier survival curves were used to show that the median time for a favorable outcome was 66 days (95% confidence interval [CI] = 48.50–83.50 days) in the DTI-assisted neuroendoscopy group and 104 days (95% CI = 75.55–132.45 days) in the standard neuroendoscopy group. Log-rank testing showed that the DTI-assisted neuroendoscopy group had a lower pulmonary infection rate ( χ 2 = 4.706, P = 0.030) and a better prognosis ( χ 2 = 5.223, P = 0.022) than the standard neuroendoscopy group. The survival rate did not differ significantly between the DTI-assisted neuroendoscopy group and the standard neuroendoscopy group ( P > 0.05). Conclusions The use of DTI in neuroendoscopic hematoma removal can significantly improve neurological function outcomes in patients, but it does not significantly affect the mortality of patients.

中文翻译：

---

一种治疗自发性颅内出血的新手术方法

目的本研究旨在确定DTI辅助神经内镜治疗颅内出血（ICH）的安全性和有效性。方法 这项回顾性研究纳入了 260 例接受神经内镜血肿清除术的自发性幕上 ICH 患者的临床资料。根据他们接受的手术方法将患者分组：DTI辅助神经内窥镜检查（69例）和标准神经内窥镜检查（191例）。所有患者均随访6个月。多因素logistic回归分析影响患者预后的危险因素。使用 Kaplan-Meier 生存曲线比较两组的结果。结果DTI辅助神经内镜组的预后改良Rankin量表（mRS）评分明显优于标准神经内镜组（P=0.027）。Logistic 回归分析表明，DTI 辅助神经内镜检查是获得良好结果的独立保护因素（模型 1：优势比 [OR] = 0.42，P = 0.015；模型 2：OR = 0.40，P = 0.013）。使用 Kaplan-Meier 生存曲线显示，DTI 辅助神经内窥镜组获得良好结果的中位时间为 66 天（95% 置信区间 [CI] = 48.50-83.50 天）和 104 天（95% CI = 75.55 –132.45 天）在标准神经内窥镜组中。对数秩检验显示，DTI辅助神经内镜组肺部感染率低于标准神经内镜组（χ 2 = 4.706，P = 0.030），预后较好（χ 2 = 5.223，P = 0.022）。DTI辅助神经内镜组与标准神经内镜组生存率差异无统计学意义（ P > 0.05）。